Workflow
IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances
Prnewswire·2025-10-13 12:30

ProSense® and IceCure received a high level of interest during a cryoablation faculty led by Dr. Richard Fine, a leading investigator of IceCure's ICE3 trail, the largest cryoablation study of its kind in the U.S. Dr. Fine is winner of the 2024 American Society of Breast Surgeons' Scientific Impact Award for his presentation of the ICE3 trial data and lead author of an ICE3 study published in the Annals of Surgical Oncology. IceCure delivered a product showcase presentation focused on ProSense®'s current ca ...